Comparison

LY-364947 European Partner

Item no. HY-13462-10mM
Manufacturer MedChem Express
CASRN 396129-53-6
Amount 10mM/1mL
Quantity options 10mM/1mL 10 mg 50 mg 5 mg
Category
Type Inhibitors
Clone N/A
Specific against other
Purity 99.14
Formula C17H12N4
Citations [1]Oka M, et al. Inhibition of endogenous TGF-beta signaling enhances lymphangiogenesis. Blood, 2008, 111(9), 4571-4579.<br>[2]Naka K, et al. TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature, 2010, 463(7281), 676-680.<br>[3]Peng SB, et al. Kinetic characterization of novel pyrazole TGF-beta receptor I kinase inhibitors and their blockade of the epithelial-mesenchymal transition. Biochemistry, 2005, 44(7), 2293-2304.
Smiles C1(C2=CNN=C2C3=NC=CC=C3)=CC=NC4=CC=CC=C14
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias HTS466284
Available
Product Description
LY-364947 (HTS466284) is a potent ATP-competitive inhibitor of TGFβR-I with IC50 of 59 nM, and exhibits 7-fold selectivity over TGFβR-II[1].
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
Cancer-Kinase/protease
MolecularWeight
272.30
Clinical_Information
No Development Reported
Manufacturers Research Area
Cancer
Solubility
DMSO : 15.62 mg/mL (ultrasonic; warming; heat to 60°C)
Manufacturers Target
TGF-β Receptor
Pathway
TGF-beta/Smad

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10mM/1mL
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close